Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07818226) titled 'Effects of GLP-1 Receptor Agonists on Saliva and Oral Health' on Sept. 2.
Study Type: Observational
Primary Sponsor: Kirikkale University
Condition:
Type 2 Diabetes
Obesity & Overweight
Xerostomia
Dental Caries
Intervention:
Drug: GLP-1 Receptor Agonists
Recruitment Status: Not recruiting
Date of First Enrollment: October 16, 2026
Target Sample Size: 50
Countries of Recruitment:
Turkey (Turkiye)
To know more, visit https://clinicaltrials.gov/study/NCT07818226
Disclaimer: Curated by HT Syndication....